- Home
- GALT vs SOL Comparison
GALT vs SOL Comparison
Compare GALT & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- SOL
- Stock Information
- Founded
- GALT 2000
- SOL 2005
- Country
- GALT United States
- SOL United States
- Employees
- GALT N/A
- SOL N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- SOL Semiconductors
- Sector
- GALT Health Care
- SOL Technology
- Exchange
- GALT Nasdaq
- SOL Nasdaq
- Market Cap
- GALT 86.0M
- SOL 84.6M
- IPO Year
- GALT N/A
- SOL 2008
- Fundamental
- Price
- GALT $1.38
- SOL $1.48
- Analyst Decision
- GALT Hold
- SOL Buy
- Analyst Count
- GALT 1
- SOL 3
- Target Price
- GALT N/A
- SOL $3.50
- AVG Volume (30 Days)
- GALT 177.7K
- SOL 165.9K
- Earning Date
- GALT 05-19-2025
- SOL 05-22-2025
- Dividend Yield
- GALT N/A
- SOL N/A
- EPS Growth
- GALT N/A
- SOL N/A
- EPS
- GALT N/A
- SOL N/A
- Revenue
- GALT N/A
- SOL $92,067,000.00
- Revenue This Year
- GALT N/A
- SOL N/A
- Revenue Next Year
- GALT N/A
- SOL $45.37
- P/E Ratio
- GALT N/A
- SOL N/A
- Revenue Growth
- GALT N/A
- SOL N/A
- 52 Week Low
- GALT $0.73
- SOL $1.04
- 52 Week High
- GALT $3.41
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- GALT 49.81
- SOL 56.58
- Support Level
- GALT $1.26
- SOL $1.25
- Resistance Level
- GALT $1.63
- SOL $1.40
- Average True Range (ATR)
- GALT 0.13
- SOL 0.07
- MACD
- GALT 0.02
- SOL 0.03
- Stochastic Oscillator
- GALT 37.50
- SOL 79.39
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.